ECDC, WHO and the German Federal Centre for Health Education (BZgA) have jointly developed public health advice for UEFA EURO 2024 to promote the safety and well-being of spectators attending matches.
In connection with the European Immunization Week, ECDC releases data indicating an increase in cases of vaccine-preventable diseases such as measles and pertussis, after decreased levels during the COVID-19 pandemic.
Since April 2023, over 300 shigellosis cases, many with multidrug-resistant Shigella sonnei -infections, have been reported to the European Centre for Disease Prevention and Control (ECDC).
Vector sampling protocols outlining the recommended methods for collecting vectors have been issued today by ECDC and EFSA, to support entomologists and public-health professionals in Europe. It is a first attempt to summarise best-practices in terms of methods and strategies for sampling mosquitoes, sandflies, biting midges and ticks.
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
ECDC releases today an update of its tick-borne diseases communication toolkit to support public health authorities in devising communication initiatives as part of their tick-borne diseases prevention programmes.
The authors assess the risk of pertussis in children in California relative to the time since the fifth dose of DTaP from 2006 to 2011 (this period included a large outbreak in 2010).
This study, strong of an almost complete follow-up of all children born in Denmark from 2003 to 2008, provides evidence that the DTaP-IPV-HiB vaccine is not associated to an overall increased risk of febrile seizures and epilepsy.